Browsing: biopharma nl

Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…

Medical device innovation is laborious because of the high bar for validating that the technology does no harm. Patient recruitment…

Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for…

Kailera Therapeutics isn’t the only company developing an obesity drug that hits multiple targets for weight loss, but the clinical-stage…

In 2006, Fujifilm faced an existential crisis when people stopped buying camera film in favor of digital cameras. Almost overnight…

A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a…

Hunter syndrome patients can manage the disorder with a drug that addresses disease symptoms throughout the body except the brain…

Clinical trials don’t fail because patients aren’t willing to participate. They fail because we never find most of the people…

The pandemic-prompted social isolation, the rise of social media — with its ability to spread misinformation at the speed of…

Aldeyra Therapeutics’ drug for dry eye disease has been rejected by the FDA, marking the third time in three years…